Neoadjuvant Immunotherapy for NSCLC: Current Concepts and Future Approaches von Uprety, Dipesh, Mandrekar, Sumithra J., Wigle, Dennis, Roden, Anja C., Adjei, Alex A.

Volltext

Pembrolizumab as adjuvant therapy in non-small-cell lung cancer von Uprety, Dipesh

Volltext

Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody–Drug Conjugate von Lashari, Bilal H., Vallatharasu, Yazhini, Kolandra, Lakshmi, Hamid, Mohsin, Uprety, Dipesh

Volltext

Osimertinib Should Not Yet Be Considered the Standard of Care for EGFR-Mutant NSCLC in the Adjuvant Setting von Uprety, Dipesh

Volltext

Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments von Uprety, Dipesh, Halfdanarson, Thorvardur R., Molina, Julian R, Leventakos, Konstantinos

Volltext

Chemoimmunotherapy for stage IV non-small-cell lung cancer von Uprety, Dipesh

Volltext

Association between cannabis use and clinical outcomes in patients with solid malignancies receiving immune checkpoint inhibitors von Hadid, Tarik, Biedny, Adam, Mamdani, Hirva, Azmi, Asfar, Kim, Seongho, Jang, Hyejeong, Uprety, Dipesh, Al Hallak, Mohammed Najeeb, Sukari, Ammar

Volltext

The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer von Nagasaka, Misako, Singh, Vijendra, Baca, Yasmine, Sukari, Ammar, Kim, Chul, Mamdani, Hirva, Spira, Alexander I., Uprety, Dipesh, Bepler, Gerold, Kim, Edward S., Raez, Luis E., Pai, Sachin Gopalkrishna, Ikpeazu, Chukwuemeka, Oberley, Matthew, Feldman, Rebecca, Xiu, Joanne, Korn, W. Michael, Wozniak, Antoinette J., Borghaei, Hossein, Liu, Stephen V.

Volltext

CheckMate 743: A Glimmer of Hope for Malignant Pleural Mesothelioma von Uprety, Dipesh

Volltext

A challenging case of stage IV EGFR-mutant lung cancer with histologic transformation and multiple resistance mechanisms von Rivera-Concepcion, Joel, Lo, Ying-Chun, Uprety, Dipesh, Adjei, Alex A., Ernani, Vinicius, Leventakos, Konstantinos

Volltext

KRAS: From undruggable to a druggable Cancer Target von Uprety, Dipesh, Adjei, Alex A.

Volltext

529 Impact of histology and PD-L1 status on immune checkpoint inhibitors in the treatment of non-small cell lung cancer von Choucair, Khalil, Jang, Hyejong, Jalal, Shadia I, Hadid, Tarik, Uprety, Dipesh, Kim, Seongho, Mamdani, Hirva

Volltext

Drug Combinations with Transplantation for Myeloma von Uprety, Dipesh

Volltext

Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinoma von Choucair, Khalil, Elliott, Andrew, Oberley, Matthew James, Walker, Phillip, Salama, April K, Saeed, Azhar, Mamdani, Hirva, Uprety, Dipesh, El-Deiry, Wafik S, Beltran, Himisha, Liu, Stephen V, Kim, Chul, Naqash, Abdul Rafeh, Lou, Emil, Chen, Lujia, Saeed, Anwaar

Volltext

The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients von Uprety, Dipesh, Bista, Amir, Vallatharasu, Yazhini, Arjyal, Lubina

Volltext

Renal failure secondary to leukemic infiltration of kidneys in CLL—a case report and review of literature von Uprety, Dipesh, Peterson, Alan, Shah, Binay Kumar

Volltext

Chemo-immunotherapy: The Beginning of a New Era in Lung Cancer von Uprety, Dipesh

Volltext

Targeting the Cardiotoxicity of Epidermal Growth Factor Receptor Inhibitors von Uprety, Dipesh, Mansfield, Aaron S.

Volltext

First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non-Small-Cell Lung Cancer: Are We Ready to Use It? von Uprety, Dipesh, Remon, Jordi, Peters, Solange

Volltext

Characterization of MET Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome Sequencing von Kim, So Yeon, Yin, Jun, Bohlman, Stephen, Walker, Phillip, Dacic, Sanja, Kim, Chul, Khan, Hina, Liu, Stephen V., Ma, Patrick C., Nagasaka, Misako, Reckamp, Karen L., Abraham, Jim, Uprety, Dipesh, Wang, Feng, Xiu, Joanne, Zhang, Jian, Cheng, Haiying, Halmos, Balazs

Volltext